These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 11468182
1. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Grad JM, Bahlis NJ, Reis I, Oshiro MM, Dalton WS, Boise LH. Blood; 2001 Aug 01; 98(3):805-13. PubMed ID: 11468182 [Abstract] [Full Text] [Related]
2. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells. McCafferty-Grad J, Bahlis NJ, Krett N, Aguilar TM, Reis I, Lee KP, Boise LH. Mol Cancer Ther; 2003 Nov 01; 2(11):1155-64. PubMed ID: 14617789 [Abstract] [Full Text] [Related]
3. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Li JJ, Tang Q, Li Y, Hu BR, Ming ZY, Fu Q, Qian JQ, Xiang JZ. Acta Pharmacol Sin; 2006 Aug 01; 27(8):1078-84. PubMed ID: 16867262 [Abstract] [Full Text] [Related]
4. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Dai J, Weinberg RS, Waxman S, Jing Y. Blood; 1999 Jan 01; 93(1):268-77. PubMed ID: 9864170 [Abstract] [Full Text] [Related]
5. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. Matulis SM, Morales AA, Yehiayan L, Croutch C, Gutman D, Cai Y, Lee KP, Boise LH. Mol Cancer Ther; 2009 May 01; 8(5):1197-206. PubMed ID: 19417148 [Abstract] [Full Text] [Related]
6. [Mechanism of arsenic trioxide-induced cytotoxicity on multiple myeloma cells]. Chen YB, Hou J, Fu WJ, Ding SQ, Wang DX, Yuan ZG, Kong XT. Ai Zheng; 2003 Dec 01; 22(12):1276-9. PubMed ID: 14693051 [Abstract] [Full Text] [Related]
7. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. Hu XM, Hirano T, Oka K. Cancer Chemother Pharmacol; 2003 Jul 01; 52(1):47-58. PubMed ID: 12750841 [Abstract] [Full Text] [Related]
8. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion. You BR, Park WH. Oncol Rep; 2012 Aug 01; 28(2):749-57. PubMed ID: 22684917 [Abstract] [Full Text] [Related]
9. Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: enhancement of apoptosis by manipulation of cellular redox state. Gartenhaus RB, Prachand SN, Paniaqua M, Li Y, Gordon LI. Clin Cancer Res; 2002 Feb 01; 8(2):566-72. PubMed ID: 11839678 [Abstract] [Full Text] [Related]
10. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation. Ong PS, Chan SY, Ho PC. Int J Oncol; 2011 Jun 01; 38(6):1731-9. PubMed ID: 21455570 [Abstract] [Full Text] [Related]
11. Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro. Lin LM, Li BX, Xiao JB, Lin DH, Yang BF. World J Gastroenterol; 2005 Sep 28; 11(36):5633-7. PubMed ID: 16237756 [Abstract] [Full Text] [Related]
12. Arsenic-induced apoptosis in malignant cells in vitro. Akao Y, Yamada H, Nakagawa Y. Leuk Lymphoma; 2000 Mar 28; 37(1-2):53-63. PubMed ID: 10721769 [Abstract] [Full Text] [Related]
13. Alterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myeloma. Matulis SM, Morales AA, Yehiayan L, Lee KP, Cai Y, Boise LH. PLoS One; 2012 Mar 28; 7(12):e52662. PubMed ID: 23285138 [Abstract] [Full Text] [Related]
14. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Blood; 1999 Sep 15; 94(6):2102-11. PubMed ID: 10477740 [Abstract] [Full Text] [Related]
15. Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells. Sturlan S, Baumgartner M, Roth E, Bachleitner-Hofmann T. Blood; 2003 Jun 15; 101(12):4990-7. PubMed ID: 12609832 [Abstract] [Full Text] [Related]
16. Potentiation of arsenic trioxide-induced apoptosis by 8-bromo-7-methoxychrysin in human leukemia cells involves depletion of intracellular reduced glutathione. Xiao G, Tang X, Yao C, Wang C. Acta Biochim Biophys Sin (Shanghai); 2011 Sep 15; 43(9):712-21. PubMed ID: 21785114 [Abstract] [Full Text] [Related]
17. Suppression of arsenic trioxide-induced apoptosis in HeLa cells by N-acetylcysteine. Han YH, Kim SZ, Kim SH, Park WH. Mol Cells; 2008 Jul 31; 26(1):18-25. PubMed ID: 18511884 [Abstract] [Full Text] [Related]
18. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28). Giri U, Terry NH, Kala SV, Lieberman MW, Story MD. Cancer Chemother Pharmacol; 2005 Jun 31; 55(6):511-21. PubMed ID: 15761769 [Abstract] [Full Text] [Related]
19. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity. Zheng CY, Lam SK, Li YY, Ho JC. Int J Oncol; 2015 Mar 31; 46(3):1067-78. PubMed ID: 25572414 [Abstract] [Full Text] [Related]
20. Anticancer activity in human multiple myeloma U266 cells: synergy between cryptotanshinone and arsenic trioxide. Liu P, Xu S, Zhang M, Wang WW, Zhang YF, Rehman K, Naranmandura H, Chen Z. Metallomics; 2013 Jun 31; 5(7):871-8. PubMed ID: 23529539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]